IDYA

IDEAYA Biosciences, Inc.

37.40 USD
-0.16 (-0.43%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

IDEAYA Biosciences, Inc. stock is down -7.24% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 83.33% of the previous 5 June’s closed higher than May. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
23 Apr 15:21 21 Jun, 2024 40.00 CALL 745 0

About IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions.